Home/MG Biologics/Mark Meyer
MM

Mark Meyer

Founder / Owner / Chairman of the Board

MG Biologics

MG Biologics Pipeline

DrugIndicationPhase
Rhodococcus Equi Antibody OptimizationRhodococcus equi infection in foalsResearch
ImmunoGutGastrointestinal support against E. coli, Parvovirus, Salmonella, C. difficileCommercial
Custom Blend ProgramFarm-specific pathogen combinationsService